Cargando…
Galectin-3 in NAFLD: Therapeutic Target or Noncausal Biomarker?
Autor principal: | Soccio, Raymond E |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8372627/ https://www.ncbi.nlm.nih.gov/pubmed/34019644 http://dx.doi.org/10.1210/clinem/dgab363 |
Ejemplares similares
-
Noncausal stochastic calculus
por: Ogawa, Shigeyoshi
Publicado: (2017) -
Effect of Gut Microbiota and PNPLA3 rs738409 Variant on Nonalcoholic Fatty Liver Disease (NAFLD) in Obese Youth
por: Monga Kravetz, Ayesha, et al.
Publicado: (2020) -
Causal or Noncausal Relationship of Uric Acid With Diabetes
por: Johnson, Richard J., et al.
Publicado: (2015) -
The Causal Relationship Between Sleep and Obesity: Novel Insights and Therapeutic Target
por: Wang, Jun, et al.
Publicado: (2022) -
GIP as a Therapeutic Target in Diabetes and Obesity: Insight From Incretin Co-agonists
por: Holst, Jens Juul, et al.
Publicado: (2020)